Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
New England Journal of Medicine · 11.09.2025 · 393 (10) · 949-960
DOI: 10.1056/nejmoa2504654 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 11.09.2025. Verfasst von Pablo Garcia-Pavia und 33 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Puerta de Hierro de Majadahonda, Instituto Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Centro de Investigación …. Hauptthemen laut MEDLINE: Adrenergic beta-1 Receptor Antagonists, Cardiomyopathy, Hypertrophic, Metoprolol, Oxygen Consumption. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Cytokinetics.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital Universitario Puerta de Hierro de Majadahonda, Instituto Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Madrid.
- Centro Nacional de Investigaciones Cardiovasculares, Madrid.
- Lahey Hospital and Medical Center, Burlington, MA.
- Oregon Health and Science University, Portland.
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
- University of Missouri Kansas City Healthcare Institute for Innovations in Quality, Kansas City.
ORCID-Profile: Perry Elliott, Sheila M Hegde, Ajith Nair, Scott D Solomon
Förderung
- Cytokinetics
Zitieren
APA
Garcia-Pavia, P., Maron, M. S., Masri, A., Merkely, B., Nassif, M. E., Peña-Peña, M. L., Barriales-Villa, R., Bilen, O., Burroughs, M., Claggett, B., Costabel, J. P., Correia, E. B., Dybro, A. M., Elliott, P., Hegde, S. M., Lakdawala, N. K., Lewis, G. D., Mann, A., Miao, Z. M., …, & MAPLE-HCM Investigators (2025). Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine, 393(10), 949-960. https://doi.org/10.1056/nejmoa2504654
Vancouver
Garcia-Pavia P, Maron MS, Masri A, Merkely B, Nassif ME, Peña-Peña ML, et al. Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine. 2025;393(10):949-960. doi:10.1056/nejmoa2504654
BibTeX
@article{GarciaPavia2025,
author = {Garcia-Pavia, Pablo and Maron, Martin S and Masri, Ahmad and Merkely, Bela and Nassif, Michael E and Peña-Peña, Maria Luisa and Barriales-Villa, Roberto and Bilen, Ozlem and Burroughs, Melissa and Claggett, Brian and Costabel, Juan Pablo and Correia, Edileide de Barros and Dybro, Anne M and Elliott, Perry and Hegde, Sheila M and Lakdawala, Neal K and Lewis, Gregory D and Mann, Amy and Miao, Zi Michael and Nair, Ajith and Poulsen, Steen H and Reant, Patricia and Schulze, P Christian and Solomon, Scott D and Wang, Andrew and Sohn, Regina and Berhane, Indrias and Heitner, Stephen B and Jacoby, Daniel L and Kupfer, Stuart and Malik, Fady I and Wohltman, Amy and Fifer, Michael A and MAPLE-HCM Investigators, MAPLE-HCM Investigators},
title = {Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {10},
pages = {949--960},
doi = {10.1056/nejmoa2504654}
}
EUVIMED